Gsa Capital Partners LLP Graphite Bio, Inc. Transaction History

Gsa Capital Partners LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$1.85 - $3.21 $322,664 - $559,865	-174,413 Reduced 81.31%	40,079 $98,000
Q4 2022 Feb 13, 2023	BUY	$2.82 - $3.59 $67,084 - $85,402	23,789 Added 12.47%	214,492 $712,000
Q3 2022 Nov 14, 2022	BUY	$2.82 - $4.24 $249,152 - $374,612	88,352 Added 86.32%	190,703 $605,000
Q2 2022 Aug 09, 2022	BUY	$2.14 - $5.23 $219,031 - $535,295	102,351 New	102,351 $281,000

637K

Ticker GRPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,211,200
Description
Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expres...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.